Evaluation of Pharmacokinetic Interaction Between PA-824 and Midazolam in Healthy Adult Subjects

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02632-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Lack of a Pharmacokinetic Interaction Between Steady-State Roflumilast and Single-Dose Midazolam in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

No Clinically Significant Pharmacokinetic Interactions Between Dolutegravir and Daclatasvir in Healthy Adult Subjects

BMC Infectious Diseases
Infectious Diseases
2016English

Lack of Pharmacokinetic Interaction Between Retigabine and Phenobarbitone at Steady-State in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2003English

Pharmacokinetic Interactions Between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Synthesis and Evaluation of Pretomanid (PA-824) Oxazolidinone Hybrids

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Absence of Pharmacokinetic and Pharmacodynamic Interactions Between Almorexant and Warfarin in Healthy Subjects

Drugs in R and D
Pharmacology
2013English

Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects

Drugs in R and D
Pharmacology
2011English

Pharmacokinetic Interaction Between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Subjects: A Prospective, Open-Label, Fixed-Sequence, Cross-Over Study

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy